Financhill
Back

Matinas BioPharma Holdings Vs. Merck & Industry Stock Comparison

Sell
38

MTNB
Matinas BioPharma Holdings

Last Price:
0.58
Seasonality Move:
5.28%
Sell
27

MRK
Merck &

Last Price:
99.85
Seasonality Move:
3.55%
Sell
38
Matinas BioPharma Holdings (MTNB) is a Sell

Is Matinas BioPharma Holdings a Buy, Sell or Hold?

  • The current Matinas BioPharma Holdings [MTNB] share price is $0.58. The Score for MTNB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • MTNB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Merck & (MRK) is a Sell

Is Merck & a Buy, Sell or Hold?

  • The current Merck & [MRK] share price is $99.86. The Score for MRK is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • MRK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MTNB Stock Price Chart

What is Matinas BioPharma Holdings's stock price today?

  • The Matinas BioPharma Holdings share price today is $0.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTNB is experiencing buying pressure, which is a positive indicator for future bullish movement.

MRK Stock Price Chart

What is Merck &'s stock price today?

  • The Merck & share price today is $99.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRK is experiencing buying pressure, which is a positive indicator for future bullish movement.

MTNB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.57 Sell
Relative Strength Index (14 RSI): 23.95 Sell
Chaikin Money Flow: 119933 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.26 - 2.88) Sell
Bollinger Bands (100): (0 - 3.16) Sell

MRK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.86 Sell
Relative Strength Index (14 RSI): 41.27 Sell
Chaikin Money Flow: 10140740 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (98.4 - 105.3) Sell
Bollinger Bands (100): (104.93 - 122.01) Sell

MTNB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.63 Sell
20-day SMA: 1.06 Sell
50-day SMA: 2.51 Sell
200-day SMA: 0.89 Sell
8-day EMA: 0.65 Sell
20-day EMA: 1.14 Sell
50-day EMA: 1.73 Sell
200-day EMA: 1.19 Sell

MRK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 97.77 Buy
20-day SMA: 100.61 Sell
50-day SMA: 107.54 Sell
200-day SMA: 120.56 Sell
8-day EMA: 98.45 Buy
20-day EMA: 100.78 Sell
50-day EMA: 106.05 Sell
200-day EMA: 114.81 Sell

Matinas BioPharma Holdings Earnings Growth & MTNB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and an increase next year of $1.06 per share.

Merck & Earnings Growth & MRK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.36 per share, and an increase next year of $1.75 per share.

Matinas BioPharma Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Merck & Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):